| Financial Year |
March 31 2023 |
| Monetary Funds |
189,411,113.61 |
| Held-for-trading Financial Assets |
496,000.00 |
| Notes Receivable |
23,982,891.04 |
| Accounts Receivable |
518,172,634.54 |
| Advances to Suppliers |
5,555,542.69 |
| Other Receivables |
21,478,027.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
79,879,591.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,912,908.54 |
| Total Current Assets |
884,013,199.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
26,424,673.59 |
| Fixed Assetes |
531,177,040.24 |
| Under-construction Projects |
12,454,478.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,531,859.60 |
| R&D expenses |
-- |
| Goodwill |
297,944,071.44 |
| Long-Term Deferred and Prepaid Expenses |
12,277,574.67 |
| Deferred Income Tax Assets |
59,681,330.47 |
| Other Non-Current Assets |
233,660.00 |
| Sub-Total of Non-Current Assets |
1,084,836,786.05 |
| Total Assets |
1,968,849,985.79 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
265,302,342.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,823,749.16 |
| Taxes Payable |
21,984,528.53 |
| Interest Payable |
-- |
| Dividend Payable |
26,637,802.35 |
| Other payables |
62,807,172.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,021,187.98 |
| Other Current Liabilities |
15,620,278.98 |
| Sub-Total of Current Liabilities |
423,745,066.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,561,434.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,839,679.33 |
| Total Liabilities |
435,584,745.74 |
| Paid-In Capital(Or Share Stock) |
500,845,351.00 |
| Capital Surplus |
356,878,500.18 |
| Surplus Reserve |
19,235,029.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
613,621,176.39 |
| Minority Stockholder's Interest |
42,575,388.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,490,689,851.46 |
| Owner's Equity（Stockholder's Equity） |
1,533,265,240.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,968,849,985.79 |
